Latest Insider Transactions at Merck & Co., Inc. (MRK)
This section provides a real-time view of insider transactions for Merck & Co., Inc. (MRK). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Merck & Co., Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Merck & Co., Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Nov 04
2021
|
Caroline Litchfield EVP & CFO |
SELL
Open market or private sale
|
Direct |
18,335
-43.19%
|
$1,668,485
$91.0 P/Share
|
Nov 04
2021
|
Caroline Litchfield EVP & CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
22,683
+34.83%
|
-
|
Nov 04
2021
|
Richard R. De Luca EVP&Pres, Merck Animal Heallth |
SELL
Open market or private sale
|
Direct |
29,782
-20.3%
|
$2,680,380
$90.4 P/Share
|
Nov 04
2021
|
Richard R. De Luca EVP&Pres, Merck Animal Heallth |
BUY
Exercise of conversion of derivative security
|
Direct |
29,782
+16.87%
|
-
|
Nov 03
2021
|
Rita A Karachun Sr. VP Fince-Global Controller |
SELL
Open market or private sale
|
Direct |
25,000
-41.12%
|
$2,200,000
$88.45 P/Share
|
Nov 03
2021
|
Rita A Karachun Sr. VP Fince-Global Controller |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+29.14%
|
-
|
Nov 01
2021
|
Julie L. Gerberding EVP, Chief Patient Officer |
SELL
Open market or private sale
|
Direct |
96,270
-71.08%
|
$8,375,490
$87.91 P/Share
|
Nov 01
2021
|
Julie L. Gerberding EVP, Chief Patient Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
96,270
+18.96%
|
-
|
Nov 01
2021
|
Frank Clyburn EVP & Pres ? Human Health |
SELL
Open market or private sale
|
Direct |
39,762
-29.05%
|
$3,459,294
$87.87 P/Share
|
Nov 01
2021
|
Frank Clyburn EVP & Pres ? Human Health |
BUY
Exercise of conversion of derivative security
|
Direct |
39,762
+13.6%
|
-
|
Oct 30
2021
|
Steven Mizell EVP, Chief HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,323
-8.33%
|
$204,424
$88.05 P/Share
|
Oct 30
2021
|
Steven Mizell EVP, Chief HR Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,715
+14.46%
|
$414,920
$88.05 P/Share
|
Oct 30
2021
|
Frank Clyburn EVP & Pres ? Human Health |
SELL
Payment of exercise price or tax liability
|
Direct |
1,162
-1.18%
|
$102,256
$88.05 P/Share
|
Oct 30
2021
|
Frank Clyburn EVP & Pres ? Human Health |
BUY
Exercise of conversion of derivative security
|
Direct |
2,358
+2.34%
|
$207,504
$88.05 P/Share
|
Oct 29
2021
|
Richard R. De Luca EVP&Pres, Merck Animal Heallth |
SELL
Open market or private sale
|
Direct |
135,405
-53.66%
|
$11,780,235
$87.56 P/Share
|
Oct 29
2021
|
Richard R. De Luca EVP&Pres, Merck Animal Heallth |
BUY
Exercise of conversion of derivative security
|
Direct |
135,405
+23.79%
|
-
|
Oct 29
2021
|
Sanat Chattopadhyay Exe V-P & Pres. MMD |
SELL
Open market or private sale
|
Direct |
24,619
-20.91%
|
$2,141,853
$87.32 P/Share
|
Oct 29
2021
|
Sanat Chattopadhyay Exe V-P & Pres. MMD |
BUY
Exercise of conversion of derivative security
|
Direct |
24,619
+17.29%
|
-
|
May 10
2021
|
Frank Clyburn EVP & Pres ? Human Health |
SELL
Open market or private sale
|
Direct |
19,324
-17.0%
|
$1,507,272
$78.32 P/Share
|
May 10
2021
|
Frank Clyburn EVP & Pres ? Human Health |
BUY
Exercise of conversion of derivative security
|
Direct |
19,324
+14.53%
|
-
|
May 04
2021
|
Frank Clyburn EVP & Pres ? Human Health |
SELL
Payment of exercise price or tax liability
|
Direct |
939
-0.99%
|
$70,425
$75.98 P/Share
|
May 04
2021
|
Frank Clyburn EVP & Pres ? Human Health |
BUY
Exercise of conversion of derivative security
|
Direct |
1,906
+1.96%
|
$142,950
$75.98 P/Share
|
May 04
2021
|
Lisa Le Cointe Cephas SVP Chief Ethics & Com Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
238
-9.11%
|
$17,850
$75.98 P/Share
|
May 04
2021
|
Lisa Le Cointe Cephas SVP Chief Ethics & Com Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
694
+20.99%
|
$52,050
$75.98 P/Share
|
May 04
2021
|
Jennifer Zachary EVP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
2,843
-7.69%
|
$213,225
$75.98 P/Share
|
May 04
2021
|
Jennifer Zachary EVP, General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
5,772
+13.5%
|
$432,900
$75.98 P/Share
|
May 04
2021
|
Dean Y Li Executive VP & President, MRL |
SELL
Payment of exercise price or tax liability
|
Direct |
238
-1.9%
|
$17,850
$75.98 P/Share
|
May 04
2021
|
Dean Y Li Executive VP & President, MRL |
BUY
Exercise of conversion of derivative security
|
Direct |
694
+5.24%
|
$52,050
$75.98 P/Share
|
May 04
2021
|
Caroline Litchfield EVP & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
489
-2.42%
|
$36,675
$75.98 P/Share
|
May 04
2021
|
Caroline Litchfield EVP & CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
1,039
+4.89%
|
$77,925
$75.98 P/Share
|
May 04
2021
|
Rita A Karachun Sr. VP Fince-Global Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
416
-1.15%
|
$31,200
$75.98 P/Share
|
May 04
2021
|
Rita A Karachun Sr. VP Fince-Global Controller |
BUY
Exercise of conversion of derivative security
|
Direct |
1,212
+3.24%
|
$90,900
$75.98 P/Share
|
May 04
2021
|
David Michael Williams EVP,Chief Info&Digital Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
143
-2.53%
|
$10,725
$75.98 P/Share
|
May 04
2021
|
David Michael Williams EVP,Chief Info&Digital Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
417
+6.86%
|
$31,275
$75.98 P/Share
|
May 03
2021
|
Rita A Karachun Sr. VP Fince-Global Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
300
-0.85%
|
$22,200
$74.5 P/Share
|
May 03
2021
|
Rita A Karachun Sr. VP Fince-Global Controller |
BUY
Exercise of conversion of derivative security
|
Direct |
875
+2.42%
|
$64,750
$74.5 P/Share
|
May 03
2021
|
David Michael Williams EVP,Chief Info&Digital Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
142
-2.64%
|
$10,508
$74.5 P/Share
|
May 03
2021
|
David Michael Williams EVP,Chief Info&Digital Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
412
+7.11%
|
$30,488
$74.5 P/Share
|
May 03
2021
|
Dean Y Li Executive VP & President, MRL |
SELL
Payment of exercise price or tax liability
|
Direct |
257
-2.12%
|
$19,018
$74.5 P/Share
|
May 03
2021
|
Dean Y Li Executive VP & President, MRL |
BUY
Exercise of conversion of derivative security
|
Direct |
750
+5.83%
|
$55,500
$74.5 P/Share
|
May 03
2021
|
Caroline Litchfield EVP & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
353
-1.81%
|
$26,122
$74.5 P/Share
|
May 03
2021
|
Caroline Litchfield EVP & CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
750
+3.7%
|
$55,500
$74.5 P/Share
|
May 03
2021
|
Lisa Le Cointe Cephas SVP Chief Ethics & Com Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
150
-7.25%
|
$11,100
$74.5 P/Share
|
May 03
2021
|
Lisa Le Cointe Cephas SVP Chief Ethics & Com Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
437
+17.45%
|
$32,338
$74.5 P/Share
|
May 01
2021
|
Rita A Karachun Sr. VP Fince-Global Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
309
-0.89%
|
$22,866
$74.5 P/Share
|
May 01
2021
|
Rita A Karachun Sr. VP Fince-Global Controller |
BUY
Exercise of conversion of derivative security
|
Direct |
901
+2.53%
|
$66,674
$74.5 P/Share
|
May 01
2021
|
David Michael Williams EVP,Chief Info&Digital Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
192
-3.72%
|
$14,208
$74.5 P/Share
|
May 01
2021
|
David Michael Williams EVP,Chief Info&Digital Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
560
+9.78%
|
$41,440
$74.5 P/Share
|
May 01
2021
|
Dean Y Li Executive VP & President, MRL |
SELL
Payment of exercise price or tax liability
|
Direct |
354
-3.02%
|
$26,196
$74.5 P/Share
|
May 01
2021
|
Dean Y Li Executive VP & President, MRL |
BUY
Exercise of conversion of derivative security
|
Direct |
1,030
+8.08%
|
$76,220
$74.5 P/Share
|